Obesity Clinical Trial
Official title:
The Role of Phosphorus in Diet Induced Thermogenesis of Both Lean and Obese Subjects
The study aim at:
Investigating the impact of phosphorus ingestion on DIT of lean and obese subjects consuming
high carbohydrate meal.
Investigating the impact of phosphorus ingestion on DIT of lean and obese subjects consuming
high protein-low phosphorus meal.
Subject will be advice to take a weight maintenance diet which contains at least 250-300g of
carbohydrate per day for the 3 days before each study day and also he/she will be asked to
avoid any intense physical activity during the day before the day of the test. Overnight
fasted subjects (> 8 hours) will be requested to attend the testing room at around 8:00 am.
The he investigators will take the anthropometric measurements (weight, height, waist
circumference) and determine blood glucose.
A crossover design study will be used in which each subject will undertake 2 or 3 sessions in
a random order over 2 or 3 different days which are separated by a minimum of one week. The
difference between the sessions is the ingestion of placebo ( 4 tablets) or phosphorus (4
tablets, each contain 125mgof phosphorus) tablets with the appropriate meal.
Specific Aim 1: The impact of phosphorus ingestion on DIT of lean and obese subjects
consuming high carbohydrate meal (Table 1: Meal 1).
This will be divided into two experiments:
Experiment 1.1: The impact of phosphorus ingestion on DIT of lean subjects consuming high
carbohydrate meal (16 subjects).
In this experiment, overnight fasted lean subjects (> 8 hours) will be requested to attend
the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist
circumference) will be taken, rest for 30 min, measure resting energy expenditure (REE) for
30 min, ingest meal with the appropriate supplement and measure postprandial energy
expenditure (PEE) for 4 hours (see figure 3). In this experiment, subject will undertake 3
sessions in a random order over 3 different days which are separated by a minimum of one
week.
Session 1: Ingestion of phosphorus tablets (4 tablets) alone. No meal. Needed to determine
the impact of phosphorus alone on DIT Session 2: Ingestion of phosphorus tablets (4 tablets)
with the high carbohydrate meal (table1: Meal 1).
Session 3: Ingestion of placebo tablets (4 tablets) with the high carbohydrate meal (table 1:
Meal 1).
Experiment 1.2: The impact of phosphorus ingestion on DIT of lean subjects consuming high
carbohydrate meal (16 subjects).
In this experiment, overnight fasted obese subjects (> 8 hours) will be requested to attend
the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist
circumference) will be taken, rest for 30 min, measure resting REE for 30 min, ingest meal
with the appropriate supplement and measure PEE for 4 hours (see figure 3). In this
experiment, subject will undertake 3 sessions in a random order over 3 different days which
are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tables) alone. No meal. Needed to determine the
impact of phosphorus alone on DIT Session 2: Ingestion of phosphorus tablets (4 tables) with
the high carbohydrate meal (Table 1:Meal 1).
Session 3: Ingestion of placebo tablets (4 tables) with the high carbohydrate meal (Table
1:Meal 1).
Specific Aim 2: The impact of phosphorus ingestion on DIT of lean and obese subjects
consuming high protein-low phosphorus meal (table 1: Meal 2).
This will be divided into two experiments:
Experiment 2.1: The impact of phosphorus ingestion on DIT of lean and obese subjects
consuming high protein-low phosphorus meal (16 subjects).
In this experiment, overnight fasted lean subjects (> 8 hours) will be requested to attend
the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist
circumference) will be taken, rest for 30 min, measure REE for 30 min, ingest meal with the
appropriate supplement and measure PEE for 4 hours (see figure 3). In this experiment,
subject will undertake 2 sessions in a random order over 2 different days which are separated
by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) with the high protein meal (table1:
Meal 2).
Session 2: Ingestion of placebo tablets (4 tablets) with the high protein meal (table 1: Meal
2).
Experiment 2.2: The impact of phosphorus ingestion on DIT of lean and obese subjects
consuming high protein-low phosphorus meal (16 subjects).
In this experiment, overnight fasted obese subjects (> 8 hours) will be requested to attend
the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist
circumference) will be taken, rest for 30 min, measure REE for 30 min, ingest meal with the
appropriate supplement and measure PEE for 4 hours (see figure 3). Urine sample over the
experimental period will be collected. In this experiment, subject will undertake 2 sessions
in a random order over 2 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) with the high protein meal (table1:
Meal 2).
Session 2: Ingestion of placebo tablets (4 tablets) with the high protein meal (table 1: Meal
2).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |